Clinical Trial Update: Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial of tacrolimus ointment (PROTOPIC) for maintenance treatment of severe seborrheic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seborrheic Dermatitis

Drugs mentioned

• Protopic (tacrolimus)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Severe Seborrheic Dermatitis | Phase 3 | Status: COMPLETED